Tobin Schilke is a proven leader with a significant background in biopharmaceutical finance. With extensive experience in capital structure planning, equity and debt offerings, mergers and acquisitions, and financial decision support, Tobin has proven himself as a trusted advisor in the industry. Tobin's background in chemical engineering, combined with his expertise in finance, makes him a unique player in the biopharmaceutical industry. Tobin has held leadership positions at many notable companies, including his current position at Revance Therapeutics and previous positions at Achaogen, Roche, and Genentech. Tobin has significant experience in team leadership, business partnership, operational leadership, and global experience. As an empathic and dynamic leader, Tobin has mentored and developed future finance leaders across the biopharmaceutical industry. Tobin is a graduate of Cornell University's S.C. Johnson Graduate School of Management, where he studied for his MBA in finance, and he holds MS and BS degrees in Chemical Engineering from the University of California, Berkeley and Lafayette College, respectively.